CITIGROUP INC - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$51,231
-96.4%
15,068
-92.2%
0.00%
-100.0%
Q2 2023$1,425,827
-58.0%
193,990
-40.7%
0.00%
-50.0%
Q1 2023$3,391,439
+37.4%
327,359
+56.7%
0.00%0.0%
Q4 2022$2,467,853
-49.8%
208,963
-10.8%
0.00%
-50.0%
Q3 2022$4,918,000
+5.9%
234,321
+56.6%
0.00%
+33.3%
Q2 2022$4,644,000
+73.6%
149,622
+129.7%
0.00%
+50.0%
Q1 2022$2,675,000
-54.9%
65,140
-52.2%
0.00%
-33.3%
Q4 2021$5,926,000
+191.9%
136,329
+236.1%
0.00%
+200.0%
Q3 2021$2,030,000
-68.3%
40,557
-60.1%
0.00%
-75.0%
Q2 2021$6,397,000
+26.0%
101,558
+85.8%
0.00%
+33.3%
Q1 2021$5,078,000
+98.4%
54,654
+91.3%
0.00%
+50.0%
Q4 2020$2,560,000
+47.9%
28,570
+70.5%
0.00%
+100.0%
Q3 2020$1,731,000
-80.5%
16,759
-85.1%
0.00%
-85.7%
Q2 2020$8,880,000
+361.5%
112,296
+237.8%
0.01%
+250.0%
Q1 2020$1,924,000
+6.5%
33,242
-0.7%
0.00%
+100.0%
Q4 2019$1,806,000
-40.1%
33,478
-42.0%
0.00%
-50.0%
Q3 2019$3,017,000
+39.8%
57,701
+29.2%
0.00%0.0%
Q2 2019$2,158,000
+45.5%
44,665
+52.1%
0.00%
+100.0%
Q1 2019$1,483,000
-58.9%
29,358
-51.7%
0.00%
-75.0%
Q4 2018$3,607,000
+99.8%
60,837
+121.9%
0.00%
+100.0%
Q3 2018$1,805,000
+375.0%
27,413
+264.6%
0.00%
Q2 2018$380,000
-81.4%
7,519
-80.7%
0.00%
-100.0%
Q1 2018$2,047,000
-6.8%
38,896
-17.7%
0.00%0.0%
Q4 2017$2,196,000
+0.9%
47,274
-12.1%
0.00%0.0%
Q3 2017$2,176,000
+5.3%
53,776
-11.7%
0.00%0.0%
Q2 2017$2,067,000
+31.9%
60,934
+12.9%
0.00%
+100.0%
Q1 2017$1,567,000
-58.7%
53,967
-53.3%
0.00%
-66.7%
Q4 2016$3,797,000
+357.5%
115,636
+339.0%
0.00%
+200.0%
Q3 2016$830,000
+186.2%
26,338
+155.7%
0.00%
Q2 2016$290,000
-64.7%
10,299
-54.5%
0.00%
-100.0%
Q1 2016$821,000
+689.4%
22,619
+769.3%
0.00%
Q4 2015$104,000
+33.3%
2,602
-4.9%
0.00%
Q3 2015$78,000
-17.9%
2,736
-4.9%
0.00%
Q2 2015$95,000
-67.8%
2,876
-71.9%
0.00%
Q1 2015$295,000
+602.4%
10,248
+555.7%
0.00%
Q4 2014$42,000
-59.2%
1,563
-67.6%
0.00%
Q3 2014$103,000
-4.6%
4,823
+0.1%
0.00%
Q2 2014$108,000
+28.6%
4,820
+45.8%
0.00%
Q1 2014$84,000
-63.8%
3,307
-67.3%
0.00%
Q4 2013$232,000
+197.4%
10,116
+145.7%
0.00%
Q3 2013$78,000
-45.5%
4,118
-58.3%
0.00%
Q2 2013$143,0009,8860.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Laurus Investment Counsel Inc. 120,504$10,797,0004.20%
SNYDER CAPITAL MANAGEMENT L P 723,477$64,824,0002.12%
Hillcrest Asset Management LLC 161,428$14,464,0001.97%
RICE HALL JAMES & ASSOCIATES, LLC 587,727$52,660,0001.85%
PALISADE CAPITAL MANAGEMENT, LP 579,009$51,879,0001.33%
Pier Capital, LLC 109,786$9,837,0001.04%
Paradiem, LLC 21,320$2,286,0000.97%
EARNEST PARTNERS LLC 1,390,735$124,610,0000.86%
Ridgewood Investments LLC 10,004$1,034,0000.82%
Tygh Capital Management, Inc. 56,334$5,048,0000.78%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders